BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $2,237,168 (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 59.1%

Value ($000) $1,321,296 Shares 8,664,239 Est. Cost $8.21 Unrealized +1504.3%

MNST MONSTER BEVERAGE CORP NEW 19.0%

Value ($000) $425,370 Shares 4,656,488 Est. Cost $22.71 Unrealized +106.7%

IWM ISHARES TR 7.1%

Value ($000) $158,265 Shares 690,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 6.0%

Value ($000) $134,379 Shares 760,062 Est. Cost $27.50 Unrealized +435.4%

LCTX LINEAGE CELL THERAPEUTICS IN 4.3%

Value ($000) $96,915 Shares 34,005,379 Est. Cost $1.03 Unrealized +151.0%

— ONCOCYTE CORP 4.3%

Value ($000) $96,297 Shares 16,776,484 Est. Cost $3.38 Unrealized —

— AGEX THERAPEUTICS INC 0.2%

Value ($000) $4,646 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	8,664,239	$1,321,296	59.1%	$8.21	+1504.3%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$425,370	19.0%	$22.71	+106.7%	COM	61174X109
IWM	ISHARES TR	690,000	$158,265	7.1%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$134,379	6.0%	$27.50	+435.4%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$96,915	4.3%	$1.03	+151.0%	COM	53566P109
—	ONCOCYTE CORP	16,776,484	$96,297	4.3%	$3.38	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$4,646	0.2%	$2.99	—	COM	00848H108